BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18272598)

  • 41. Regulation of Na,K-ATPase transport activity by protein kinase C.
    Pedemonte CH; Pressley TA; Lokhandwala MF; Cinelli AR
    J Membr Biol; 1997 Feb; 155(3):219-27. PubMed ID: 9050445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of Na-K-ATPase gene expression by angiotensin II in vascular smooth muscle cells.
    Ikeda U; Takahashi M; Okada K; Saito T; Shimada K
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1295-302. PubMed ID: 7943374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered signaling pathways linked to angiotensin II underpin the upregulation of renal Na(+)-ATPase in chronically undernourished rats.
    Silva PA; Muzi-Filho H; Pereira-Acácio A; Dias J; Martins JF; Landim-Vieira M; Verdoorn KS; Lara LS; Vieira-Filho LD; Cabral EV; Paixão AD; Vieyra A
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2357-66. PubMed ID: 25283821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide activates PKCalpha and inhibits Na+-K+-ATPase in opossum kidney cells.
    Liang M; Knox FG
    Am J Physiol; 1999 Dec; 277(6):F859-65. PubMed ID: 10600932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue- and isoform-specific kinetic behavior of the Na,K-ATPase.
    Munzer JS; Daly SE; Jewell-Motz EA; Lingrel JB; Blostein R
    J Biol Chem; 1994 Jun; 269(24):16668-76. PubMed ID: 8206986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of angiotensin-(1-7) on ATPase activities in several tissues.
    López Ordieres MG; Gironacci M; Rodríguez de Lores Arnaiz G; Peña C
    Regul Pept; 1998 Oct; 77(1-3):135-9. PubMed ID: 9809807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutant Phe788 --> Leu of the Na+,K+-ATPase is inhibited by micromolar concentrations of potassium and exhibits high Na+-ATPase activity at low sodium concentrations.
    Vilsen B
    Biochemistry; 1999 Aug; 38(35):11389-400. PubMed ID: 10471289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Action of Cardiotonic Steroids on Intracellular Processes in Rat Cortical Neurons.
    Lopachev AV; Lopacheva OM; Nikiforova KA; Filimonov IS; Fedorova TN; Akkuratov EE
    Biochemistry (Mosc); 2018 Feb; 83(2):140-151. PubMed ID: 29618300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical PKC-zeta and PKC-iota mediate opposing effects on MCF-7 Na+/K+ATPase activity.
    Muscella A; Storelli C; Marsigliante S
    J Cell Physiol; 2005 Nov; 205(2):278-85. PubMed ID: 15887250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional consequences of alterations to Pro328 and Leu332 located in the 4th transmembrane segment of the alpha-subunit of the rat kidney Na+,K(+)-ATPase.
    Vilsen B
    FEBS Lett; 1992 Dec; 314(3):301-7. PubMed ID: 1334848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired angiotensin II AT(1) receptor function and enhanced Na, K-ATPase affinity for sodium in proximal tubule of streptozotocin-treated diabetic rats.
    Siddiqui AH; Hussain T
    Clin Exp Hypertens; 2007 Oct; 29(7):435-44. PubMed ID: 17994353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
    De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
    Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules.
    Mujais SK; Chekal MA; Jones WJ; Hayslett JP; Katz AI
    J Clin Invest; 1985 Jul; 76(1):170-6. PubMed ID: 2991336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulatory effect of two cardioglycosides on reconstituted Na+/K(+)-ATPase in proteoliposomes.
    Cavaletto M; Giunta C; Pessione E; Pergola L
    Int J Biochem; 1991; 23(11):1267-75. PubMed ID: 1665425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of intracerebroventricular injections of ANG II and ANG II antibody on renal sodium excretion and Na+.K(+)-ATPase in rat].
    Li XL; Gao Y; Yu AQ
    Sheng Li Xue Bao; 1992 Feb; 44(1):8-14. PubMed ID: 1317974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased renal perfusion rapidly increases plasma membrane Na-K-ATPase in rat cortex by an angiotensin II-dependent mechanism.
    Yingst DR; Araghi A; Doci TM; Mattingly R; Beierwaltes WH
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1324-9. PubMed ID: 19726543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional significance of the shark Na,K-ATPase N-terminal domain. Is the structurally variable N-Terminus involved in tissue-specific regulation by FXYD proteins?
    Cornelius F; Mahmmoud YA; Meischke L; Cramb G
    Biochemistry; 2005 Oct; 44(39):13051-62. PubMed ID: 16185073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Na+-ATPase is a different entity from the (Na+ + K+)-ATPase in rat kidney basolateral plasma membranes.
    Proverbio F; Proverbio T; Marín R
    Biochim Biophys Acta; 1986 Jun; 858(1):202-5. PubMed ID: 3011092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.